News Briefing channel feed – Endpoints News

News Briefing channel feed

AbbVie’s new AI deal; Roche's PhIII win in breast cancer; SpringWorks to raise $275M

Last year

Ideaya partners with Gilead; Lilly extends offer for Point; Theseus lets go of CEO, CMO

Last year

Tharimmune's public offering; Culmination Bio raises $10M; Pepper Bio's seed round led by NFX

Last year

Flagship aims to raise $3B; Phenomic inks another pharma deal; Oncovita gets €8M for cancer vaccine

Last year

Lilly to pay up to $660M in new deal with PRISM BioLab; Boehringer partners with Phenomic AI

Last year

Aro raises $41M; Candel’s layoffs; Lilly to expand its accelerator to San Diego

Last year

AstraZeneca's KRAS deal with Yusen Jianheng; Abeona gets a PDUFA date

Last year

Syncona buys gene therapy company; Oryzon’s €45M financing agreement; InDex scraps PhIII drug

Last year

Alto Neuroscience closes $45M round; Simcere partners with Connect; Myricx licenses WuXi antibody

Last year

Chiesi’s new licensing deal with Haisco; Oxurion to file for bankruptcy; Hong Kong CDMO raises $210M

Last year

Danaher/Abcam deal set to close next month; Cereno's loan; March Biosciences to advance its CAR-T into PhII

Last year

Gilde Healthcare's €140M; EMD Serono to move US HQ to Boston; Arcturus up for $35M milestone

Last year

Almirall’s new AI deal with Absci; Jazz partners with Autifony; SAB raises $67M

Last year

Teva's new royalty deal; Selecta merges with Cartesian; Vir's hepatitis data

Last year

Vor shares new data for stem cell therapy; Melinta partners with Venatorx on antibiotic under FDA review

Last year

Intellia plans to file IND for AATD trial next year; Ascidian raises $40M

Last year

Pyxis Oncology lays off 20 employees; Xencor’s royalty sale to a pension plan; Jazz partners with MD Anderson

Last year

Sage’s PPD drug to cost $15K; Abcam shareholders vote 'yes' on Danaher deal

Last year

Zentalis shakes up PhIII plans in ovarian cancer; Halozyme's deal with Acumen; Korro's $117M private placement

Last year

Outlook to conduct another trial for wet AMD drug; Cara strikes new royalty deal

Last year

Protagonist's $50M milestone; Swiss biotech raises $27M; Kymera halts a PhI

Last year

Tonix's depression fail; Lilly exercises option in Sitryx deal; Milner stops fight against Abcam acquisition

Last year

Galera considers 'strategic' options; Novo partners with French biotech; AnHeart gets $40M

Last year

Vyne aims to raise $88M; Sanofi invests in gene therapy company; 4DMT addresses clinical hold

Last year

First page Previous page 12 13 141516 17 18 Next page Last page